is semaglutide safe what about the compounded version FDA issues warning some versions of for diabetes, weight loss Tirzepatide vs Semaglutide: What You

Most of these effects fade within the first month

In this study, 45% of patients in the treatment arm had at least a 2-point improvement in the NAS without worsening of fibrosis, compared to only 21% in the placebo arm (p = 0.0002)

While GLP-1 medications can offer significant benefits for weight management and diabetes control, they may not be suitable for everyone

Claims can reveal when a patient fills a prescription or undergoes a procedure that was billed to their insurance, but for obesity care they rarely capture the clinical details that define treatment response

Get started with comprehensive medical support and guidance on managing all aspects of treatment, including strategies for handling less-discussed side effects like sulfur burps effectively

Transitioning Medicare coverage of GLP-1s for obesity from the mandatory Medicare GLP-1 Bridge to the voluntary BALANCE model sets up the possibility that beneficiaries with coverage under the short-term program may need to switch Part D plans during the 2027 open enrollment period, with potential cost and coverage implications for other medications they use.